Overview

Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The aim of this work is to compare the effectiveness of sublingual misoprostol 400 mcg versus 800 mcg for medical treatment of the first trimester missed miscarriage.
Phase:
N/A
Details
Lead Sponsor:
hany farouk
Treatments:
Misoprostol